Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

0.661
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.61
Today|||52-Week Range
4.64
-65.03%
Year-to-Date
No recent news for Fibrocell Science Inc.

Today’s Trading

Previous close0.66
Today’s open0.70
Day’s range0.66 - 0.71
Volume848,230
Average volume (3 months)210,522
Market cap$14.8M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+54.12%
Earnings growth (this year)-106.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-27.85%
P/E ratioNM
Price/Sales77.98
Price/Book1.23

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...0.000.00%
BLPHBellerophon Therapeu...0.000.00%
MTEXMannatech Inc0.000.00%
OREXOrexigen Therapeutic...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$355.0K
Annual profit (last year)-$15.3M
Net profit margin-4,307.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
John M. Maslowski
Secretary &
Vice President-Business Administration
Sean D. Buckley
Corporate headquarters
Exton, Pennsylvania

Forecasts